Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.39
(1.19%)
CNY 3.39
(1.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 387.22 Million CNY | 4.0% |
| 2022 | 372.33 Million CNY | 13.4% |
| 2021 | 328.34 Million CNY | 247.89% |
| 2020 | 94.38 Million CNY | -87.83% |
| 2019 | 775.77 Million CNY | 50.55% |
| 2018 | 515.29 Million CNY | -31.75% |
| 2017 | 755.05 Million CNY | 100.28% |
| 2016 | 377 Million CNY | 50.2% |
| 2015 | 251 Million CNY | 0.0% |
| 2014 | 251 Million CNY | 1095.24% |
| 2013 | 21 Million CNY | -58.82% |
| 2012 | 51 Million CNY | 5000.0% |
| 2011 | 1 Million CNY | -95.24% |
| 2010 | 21 Million CNY | -30.0% |
| 2009 | 30 Million CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 20 Million CNY | 0.0% |
| 2006 | 20 Million CNY | -55.56% |
| 2005 | 45 Million CNY | -48.28% |
| 2004 | 87 Million CNY | 50.0% |
| 2003 | 58 Million CNY | 1060.0% |
| 2002 | 5 Million CNY | -23.11% |
| 2001 | 6.5 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 318.52 Million CNY | -3.99% |
| 2024 Q3 | 280.79 Million CNY | 17.72% |
| 2024 Q1 | 248.42 Million CNY | -35.84% |
| 2023 Q1 | 384.19 Million CNY | 3.19% |
| 2023 Q3 | 473.84 Million CNY | 27.8% |
| 2023 Q4 | 387.22 Million CNY | -18.28% |
| 2023 FY | 387.22 Million CNY | 4.0% |
| 2023 Q2 | 370.77 Million CNY | -3.49% |
| 2022 Q2 | 464.01 Million CNY | 38.18% |
| 2022 Q3 | 355.9 Million CNY | -23.3% |
| 2022 Q4 | 372.33 Million CNY | 4.61% |
| 2022 FY | 372.33 Million CNY | 13.4% |
| 2022 Q1 | 335.8 Million CNY | 2.27% |
| 2021 Q4 | 328.34 Million CNY | -5.57% |
| 2021 Q3 | 347.71 Million CNY | 3.16% |
| 2021 FY | 328.34 Million CNY | 247.89% |
| 2021 Q2 | 337.07 Million CNY | 38.21% |
| 2021 Q1 | 243.88 Million CNY | 158.4% |
| 2020 FY | 94.38 Million CNY | -87.83% |
| 2020 Q1 | 775.63 Million CNY | -0.02% |
| 2020 Q2 | 655.49 Million CNY | -15.49% |
| 2020 Q3 | 701.83 Million CNY | 7.07% |
| 2020 Q4 | 94.38 Million CNY | -86.55% |
| 2019 Q3 | 713 Million CNY | -0.11% |
| 2019 Q2 | 713.79 Million CNY | 33.53% |
| 2019 Q1 | 534.55 Million CNY | 3.74% |
| 2019 FY | 775.77 Million CNY | 50.55% |
| 2019 Q4 | 775.77 Million CNY | 8.8% |
| 2018 Q3 | 753.02 Million CNY | -0.09% |
| 2018 FY | 515.29 Million CNY | -31.75% |
| 2018 Q4 | 515.29 Million CNY | -31.57% |
| 2018 Q2 | 753.72 Million CNY | -0.09% |
| 2018 Q1 | 754.4 Million CNY | -0.09% |
| 2017 FY | 755.05 Million CNY | 100.28% |
| 2017 Q1 | 392.18 Million CNY | 4.03% |
| 2017 Q2 | 391.34 Million CNY | -0.21% |
| 2017 Q3 | 390.49 Million CNY | -0.22% |
| 2017 Q4 | 755.05 Million CNY | 93.36% |
| 2016 Q3 | 447 Million CNY | 54.35% |
| 2016 FY | 377 Million CNY | 50.2% |
| 2016 Q1 | 251 Million CNY | 0.0% |
| 2016 Q2 | 289.6 Million CNY | 15.38% |
| 2016 Q4 | 377 Million CNY | -15.66% |
| 2015 Q4 | 251 Million CNY | 0.0% |
| 2015 Q2 | 251 Million CNY | 0.0% |
| 2015 Q1 | 251 Million CNY | 0.0% |
| 2015 FY | 251 Million CNY | 0.0% |
| 2015 Q3 | 251 Million CNY | 0.0% |
| 2014 FY | 251 Million CNY | 1095.24% |
| 2014 Q3 | 265 Million CNY | 22.69% |
| 2014 Q4 | 251 Million CNY | -5.28% |
| 2014 Q2 | 216 Million CNY | 426.83% |
| 2014 Q1 | 41 Million CNY | 95.24% |
| 2013 FY | 21 Million CNY | -58.82% |
| 2013 Q4 | 21 Million CNY | -56.7% |
| 2013 Q1 | 51 Million CNY | 0.0% |
| 2013 Q2 | 51 Million CNY | 0.0% |
| 2013 Q3 | 48.5 Million CNY | -4.9% |
| 2012 Q4 | 51 Million CNY | 5000.0% |
| 2012 Q2 | 1 Million CNY | 0.0% |
| 2012 Q1 | 1 Million CNY | 0.0% |
| 2012 FY | 51 Million CNY | 5000.0% |
| 2012 Q3 | 1 Million CNY | 0.0% |
| 2011 FY | 1 Million CNY | -95.24% |
| 2011 Q4 | 1 Million CNY | -95.24% |
| 2011 Q3 | 21 Million CNY | 0.0% |
| 2011 Q2 | 21 Million CNY | 0.0% |
| 2011 Q1 | 21 Million CNY | 0.0% |
| 2010 FY | 21 Million CNY | -30.0% |
| 2010 Q1 | 30 Million CNY | 0.0% |
| 2010 Q2 | 35 Million CNY | 16.67% |
| 2010 Q3 | 51 Million CNY | 45.71% |
| 2010 Q4 | 21 Million CNY | -58.82% |
| 2009 Q2 | 130 Thousand CNY | 0.0% |
| 2009 Q4 | 30 Million CNY | 0.0% |
| 2009 Q3 | 30 Million CNY | 22976.92% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 FY | 30 Million CNY | 0.0% |
| 2008 Q4 | - CNY | -100.0% |
| 2008 FY | - CNY | -100.0% |
| 2008 Q1 | 20 Million CNY | 0.0% |
| 2008 Q2 | 20 Million CNY | 0.0% |
| 2008 Q3 | 20 Million CNY | 0.0% |
| 2007 Q3 | 65 Million CNY | 0.0% |
| 2007 Q1 | 66.45 Million CNY | 232.27% |
| 2007 FY | 20 Million CNY | 0.0% |
| 2007 Q2 | 65 Million CNY | -2.19% |
| 2007 Q4 | 20 Million CNY | -69.23% |
| 2006 Q2 | - CNY | -100.0% |
| 2006 Q1 | 45 Million CNY | 0.0% |
| 2006 Q4 | 20 Million CNY | 0.0% |
| 2006 FY | 20 Million CNY | -55.56% |
| 2006 Q3 | - CNY | 0.0% |
| 2005 Q3 | 95 Million CNY | 0.0% |
| 2005 Q4 | 45 Million CNY | -52.63% |
| 2005 Q1 | 87 Million CNY | 0.0% |
| 2005 FY | 45 Million CNY | -48.28% |
| 2005 Q2 | 95 Million CNY | 9.2% |
| 2004 Q4 | 87 Million CNY | -8.42% |
| 2004 Q2 | 95 Million CNY | 0.0% |
| 2004 FY | 87 Million CNY | 50.0% |
| 2004 Q1 | 95 Million CNY | 63.79% |
| 2004 Q3 | 95 Million CNY | 0.0% |
| 2003 Q4 | 58 Million CNY | 0.0% |
| 2003 FY | 58 Million CNY | 1060.0% |
| 2002 FY | 5 Million CNY | -23.11% |
| 2001 FY | 6.5 Million CNY | 0.0% |